Evaluating only Medicinia’s profile at its peak — without knowing the outcome — the model ranked Unit economics as the #1 likely cause. Documented cause: Regulation.
Key Events Timeline
FOUNDING
Medicinia founded in Mexico City to provide AI symptom checking and telemedicine referrals for Mexican patients.
FUNDING
Raised $5M Series A from Ignia Partners; app reached 500,000 downloads in first year.
REGULATORY ACTION
COFEPRIS issued formal warning requiring removal of diagnostic language from symptom checker; legal costs exceeded $300K.
SHUTDOWN
Operations ceased after Ignia declined follow-on; conversion rate never exceeded 1.2% free-to-paid.
Full Analysis
Free · no account needed
Documented cause
Medicinia was a Mexico City-based digital health platform offering AI-assisted symptom checking and telemedicine referrals. It raised $5M from Ignia Partners in 2019. COFEPRIS (Mexico's health regulator) issued compliance warnings in 2021 about the symptom checker's medical claims, requiring costly legal modifications. Simultaneously, the platform failed to convert free symptom checker users into paid telemedicine subscribers — conversion rate below 1.2%. By 2022, operating costs exceeded revenues by 4x and Ignia declined follow-on investment.
Lesson
“AI health tools face dual death: regulatory restriction on claims and failure to monetize the worried-well user.”